Literature DB >> 17333787

Adjunct therapy with corticosteroids or paracentesis for treatment of tuberculous pleural effusion.

A A Mansour1, T B Al-Rbeay.   

Abstract

To determine the effect of adjunct therapy, we carried out a prospective cohort study on 190 patients with tuberculous pleural effusion during May 2003-April 2004. Patients were divided into 3 groups. All groups were treated with anti-tuberculosis (TB) drugs for 6 months; in group 2 (n = 46) prednisolone, 30 mg/day for 10 days, was added; group 3 (n = 78) were given paracentesis to remove fluid. Fever and constitutional symptoms disappeared faster in group 2 (P > 0.05). After 10 days, there was a significantly greater reduction in the size of pleural effusion in group 2, but after 6 months the difference was not statistically significant. We found corticosteroids and therapeutic paracentesis are not necessary in the management of TB pleural effusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17333787

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

Review 1.  Corticosteroids for tuberculous pleurisy.

Authors:  Hannah Ryan; Jinho Yoo; Padmapriya Darsini
Journal:  Cochrane Database Syst Rev       Date:  2017-03-14

Review 2.  The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisy: a systematic review and meta-analysis.

Authors:  Shuanshuan Xie; Lin Lu; Ming Li; Mengting Xiong; Shunping Zhou; Guoliang Zhang; Aimei Peng; Changhui Wang
Journal:  Oncotarget       Date:  2017-05-24

3.  Pulmonary diseases and corticosteroids.

Authors:  G R Sethi; Kamal Kumar Singhal
Journal:  Indian J Pediatr       Date:  2008-11-21       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.